Janux Therapeutics, Inc.JANXNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+121.9%
Year-over-Year Change
Net other income and expenses outside core operations
3Y CAGR
+121.9%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
10.9x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| TTM | $44.04M | +47.5% |
| 2024 | $29.85M | +103.3% |
| 2023 | $14.69M | +264.2% |
| 2022 | $4.03M | +1468.9% |
| 2021 | $257000.00 | +113.2% |
| 2020 | $-1.94M | -733.0% |
| 2019 | $-233000.00 | - |